Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Roemer

Showing results (151-160 of 165) with videos related to

Pageof 17
Sort By:
Cell Reports|December 13, 2018
IGFBP7 Induces Differentiation and Loss of Survival of Human Acute Myeloid Leukemia Stem Cells without Affecting Normal HematopoiesisHan J M P Verhagen, Noortje van Gils, Tania Martiañez, et al.
Med (New York, N.Y.)|May 19, 2022
In-depth cell-free DNA sequencing reveals genomic landscape of Hodgkin's lymphoma and facilitates ultrasensitive residual disease detectionSophia Sobesky, Laman Mammadova, Melita Cirillo, et al.
Nature Communications|January 2, 2025
Integrating genetic subtypes with PET scan monitoring to predict outcome in diffuse large B-cell lymphomaMatías S Mendeville, Jurriaan Janssen, G Tjitske Los-de Vries, et al.
Blood|August 2, 2019
High frequency of inactivating tetraspanin <i>C</i> <i>D37</i> mutations in diffuse large B-cell lymphoma at immune-privileged sitesSuraya Elfrink, Charlotte M de Winde, Michiel van den Brand, et al.
Blood|January 17, 2016
Diffuse large B-cell lymphoma patient-derived xenograft models capture the molecular and biological heterogeneity of the diseaseBjoern Chapuy, Hongwei Cheng, Akira Watahiki, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 3, 2018
Major Histocompatibility Complex Class II and Programmed Death Ligand 1 Expression Predict Outcome After Programmed Death 1 Blockade in Classic Hodgkin LymphomaMargaretha G M Roemer, Robert A Redd, Fathima Zumla Cader, et al.
Journal of Extracellular Vesicles|July 23, 2021
Extracellular vesicle miRNA predict FDG-PET status in patients with classical Hodgkin LymphomaEsther E E Drees, Margaretha G M Roemer, Nils J Groenewegen, et al.
Blood|September 2, 2020
Spatial signatures identify immune escape via PD-1 as a defining feature of T-cell/histiocyte-rich large B-cell lymphomaGabriel K Griffin, Jason L Weirather, Margaretha G M Roemer, et al.
Blood|December 25, 2015
Targetable genetic features of primary testicular and primary central nervous system lymphomasBjoern Chapuy, Margaretha G M Roemer, Chip Stewart, et al.
Blood Advances|July 11, 2022
Genomic and microenvironmental landscape of stage I follicular lymphoma, compared with stage III/IVG Tjitske Los-de Vries, Wendy B C Stevens, Erik van Dijk, et al.
Pageof 17

Showing results (151-160 of 165) with videos related to

Sort By:
Pageof 17
Cell Reports|December 13, 2018
IGFBP7 Induces Differentiation and Loss of Survival of Human Acute Myeloid Leukemia Stem Cells without Affecting Normal HematopoiesisHan J M P Verhagen, Noortje van Gils, Tania Martiañez, et al.
Med (New York, N.Y.)|May 19, 2022
In-depth cell-free DNA sequencing reveals genomic landscape of Hodgkin's lymphoma and facilitates ultrasensitive residual disease detectionSophia Sobesky, Laman Mammadova, Melita Cirillo, et al.
Nature Communications|January 2, 2025
Integrating genetic subtypes with PET scan monitoring to predict outcome in diffuse large B-cell lymphomaMatías S Mendeville, Jurriaan Janssen, G Tjitske Los-de Vries, et al.
Blood|August 2, 2019
High frequency of inactivating tetraspanin <i>C</i> <i>D37</i> mutations in diffuse large B-cell lymphoma at immune-privileged sitesSuraya Elfrink, Charlotte M de Winde, Michiel van den Brand, et al.
Blood|January 17, 2016
Diffuse large B-cell lymphoma patient-derived xenograft models capture the molecular and biological heterogeneity of the diseaseBjoern Chapuy, Hongwei Cheng, Akira Watahiki, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 3, 2018
Major Histocompatibility Complex Class II and Programmed Death Ligand 1 Expression Predict Outcome After Programmed Death 1 Blockade in Classic Hodgkin LymphomaMargaretha G M Roemer, Robert A Redd, Fathima Zumla Cader, et al.
Journal of Extracellular Vesicles|July 23, 2021
Extracellular vesicle miRNA predict FDG-PET status in patients with classical Hodgkin LymphomaEsther E E Drees, Margaretha G M Roemer, Nils J Groenewegen, et al.
Blood|September 2, 2020
Spatial signatures identify immune escape via PD-1 as a defining feature of T-cell/histiocyte-rich large B-cell lymphomaGabriel K Griffin, Jason L Weirather, Margaretha G M Roemer, et al.
Blood|December 25, 2015
Targetable genetic features of primary testicular and primary central nervous system lymphomasBjoern Chapuy, Margaretha G M Roemer, Chip Stewart, et al.
Blood Advances|July 11, 2022
Genomic and microenvironmental landscape of stage I follicular lymphoma, compared with stage III/IVG Tjitske Los-de Vries, Wendy B C Stevens, Erik van Dijk, et al.
Pageof 17